Northwestern Mutual Wealth Management CO Ocugen, Inc. Transaction History

Northwestern Mutual Wealth Management CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$0.4 - $0.62 $160 - $248	400 Added 400.0%	500 $0
Q1 2023 May 15, 2023	BUY	$0.82 - $1.33 $82 - $133	100 New	100 $0
Q2 2022 Aug 04, 2022	BUY	$1.83 - $3.45 $201 - $379	110 Added 11.0%	1,110 $2,000
Q1 2022 May 09, 2022	BUY	$2.34 - $4.72 $2,340 - $4,720	1,000 New	1,000 $3,000

128

79.5M

535K

523K

Ticker OCGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,566,000
Market Cap $158M
Description
Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...

Get notified when there are updates to the investment portfolio of Northwestern Mutual Wealth Management CO, based on Form 13F filings with the SEC.

Stay updated on Northwestern Mutual Wealth Management CO with notifications on news.